Fate Therapeutics, Inc. (FATE)
USD 1.69
(-10.37%)
USD 1.69
(-10.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 63.53 Million | 96.3 Million | 55.84 Million | 31.43 Million | 10.68 Million | 4.74 Million |
| Cost of Revenue | 161.69 Million | 13.75 Million | 5.85 Million | 125.62 Million | 87.77 Million | 56.02 Million |
| Gross Profit | -98.16 Million | 82.54 Million | 49.99 Million | -94.18 Million | -77.09 Million | -51.28 Million |
| Operating Expenses | 254.04 Million | 404.68 Million | 272.84 Million | 159.51 Million | 111.4 Million | 71.83 Million |
| Selling, General and Administrative Expenses | 79.44 Million | 84.23 Million | 57.32 Million | 33.89 Million | 23.63 Million | 15.8 Million |
| Research and Development Expenses | 172.59 Million | 320.45 Million | 215.51 Million | 125.62 Million | 87.77 Million | 56.02 Million |
| Other Expenses | - | 20.82 Million | - | - | - | - |
| Cost and Expenses | 254.04 Million | 404.68 Million | 272.84 Million | 159.51 Million | 111.4 Million | 71.83 Million |
| Operating Income | -190.51 Million | -308.38 Million | -216.99 Million | -128.08 Million | -100.72 Million | -67.09 Million |
| Interest Expense | - | 5.84 Million | - | - | 1.75 Million | 1.69 Million |
| Income Tax Expense | - | -26.66 Million | -5.85 Million | -3.08 Million | -441 Thousand | 2.19 Million |
| Earnings before Tax | -160.92 Million | -281.72 Million | -212.15 Million | -173.38 Million | -98.14 Million | -66.59 Million |
| Net Income | -160.92 Million | -255.05 Million | -206.3 Million | -170.3 Million | -97.7 Million | -66.59 Million |
| Earnings Per Share Basic | -1.64 | -2.63 | -2.18 | -2.07 | -1.43 | -1.19 |
| Earnings Per Share Diluted | -1.64 | -2.63 | -2.18 | -2.07 | -1.43 | -1.19 |
| Weighted Average Shares Outstanding | 98.41 Million | 96.82 Million | 94.74 Million | 82.38 Million | 68.19 Million | 56.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 98.41 Million | 96.82 Million | 94.74 Million | 82.38 Million | 68.19 Million | 56.19 Million |
| Gross Margin | -1.55 | 0.86 | 0.90 | -3.00 | -7.22 | -10.82 |
| EBIT Margin | -2.71 | -3.20 | -3.86 | -4.00 | -9.03 | -13.69 |
| Profit Margin | -2.53 | -2.65 | -3.69 | -5.42 | -9.15 | -14.05 |
| EBITDA | -172.22 Million | -294.62 Million | -211.14 Million | -124.99 Million | -94.2 Million | -63.69 Million |
| Earnings Before Tax Margin | -3.00 | -3.20 | -3.89 | -4.07 | -9.43 | -14.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 6.77 Million | 1.92 Million | 1.67 Million | 63.53 Million | 1.94 Million | 933 Thousand |
| Cost of Revenue | 4.72 Million | 4.82 Million | 4.88 Million | 18.28 Million | 4.74 Million | 4.46 Million |
| Gross Profit | 2.05 Million | -2.89 Million | -3.2 Million | 45.25 Million | -2.79 Million | -3.53 Million |
| Operating Expenses | 47.13 Million | 48.17 Million | 44.86 Million | 222.86 Million | 53.22 Million | 63.49 Million |
| Selling, General and Administrative Expenses | 17.25 Million | 20.85 Million | 17.93 Million | - | 18.94 Million | 22.62 Million |
| Research and Development Expenses | 29.88 Million | 27.31 Million | 26.93 Million | - | 34.27 Million | 40.87 Million |
| Other Expenses | 1.82 Million | -1.08 Million | -2.97 Million | 9.88 Million | 1.41 Million | 5.42 Million |
| Cost and Expenses | 51.85 Million | 52.99 Million | 49.75 Million | 241.14 Million | 53.22 Million | 63.49 Million |
| Operating Income | -45.08 Million | -51.06 Million | -48.07 Million | -177.61 Million | -51.27 Million | -62.56 Million |
| Interest Expense | - | - | 9.71 Million | - | - | - |
| Income Tax Expense | - | 4.77 Million | 18.83 Million | 18.11 Million | -4.74 Million | -4.38 Million |
| Earnings before Tax | -38.42 Million | -48 Million | -44.12 Million | -160.92 Million | -45.17 Million | -52.75 Million |
| Net Income | -38.42 Million | -48 Million | -44.12 Million | -160.92 Million | -45.17 Million | -52.75 Million |
| Earnings Per Share Basic | -0.33 | -0.47 | -0.45 | - | -0.46 | -0.54 |
| Earnings Per Share Diluted | -0.33 | -0.47 | -0.45 | - | -0.46 | -0.54 |
| Weighted Average Shares Outstanding | 117.46 Million | 101.1 Million | 98.61 Million | 98.41 Million | 98.56 Million | 98.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 117.46 Million | 101.1 Million | 98.61 Million | 98.41 Million | 98.56 Million | 98.4 Million |
| Gross Margin | 0.30 | -1.50 | -1.91 | 0.71 | -1.44 | -3.79 |
| EBIT Margin | -5.96 | -24.02 | -25.77 | - | -26.38 | -62.27 |
| Profit Margin | -5.67 | -24.94 | -26.33 | -2.53 | -23.24 | -56.54 |
| EBITDA | -40.36 Million | -46.24 Million | -43.19 Million | - | -51.27 Million | -58.09 Million |
| Earnings Before Tax Margin | -6.66 | -26.53 | -28.68 | -2.80 | -26.38 | -67.06 |
RHIM
PNPL
MERG
WFRD
8066
MRNJ